UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 12, 2022

MARIMED INC.

(Exact name of registrant as specified in its charter)

Delaware	0-54433	27-4672745
(State or other jurisdiction<br>of incorporation)	(Commission<br>File Number)	(IRS Employer<br>Identification No.)

10 Oceana Way

Norwood, MA 02062

(Address of Principal Executive Offices)

Registrant’s telephone number, including area code: (617) 795-5140

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None.

Title of each class	Ticker symbol(s)	Name of each exchange on which registered
Not Applicable.	Not Applicable.	Not Applicable.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 8.01 Other Events.

On December 12, 2022, MariMed Inc. (the "Company") issued a press release announcing Robert Fireman, the Company's Chief Executive Officer and chairman of the Board, unexpectedly passed away. A copy of the press release is attached hereto a Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit<br>No.	Description
99.1	Press release, dated December 12, 2022, announcing the passing of Robert Fireman.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

**********

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MARIMED INC.
Dated: December 12, 2022
	By:	/s/ Susan M. Villare
		Susan M. Villare, Chief Financial Officer

Document

Exhibit 99.1

MariMed Mourns the Passing of Robert Fireman, Chairman, CEO

And Cannabis Industry Pioneer and Visionary

NORWOOD, MA, December 12, 2022 - MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced with deep sadness that Chairman, Chief Executive Officer, and co-founder Robert Fireman died unexpectedly on December 11, 2022.

The Company will provide further information on succession once the Board of Directors has had an opportunity to determine the best path forward.

"Bob Fireman worked tirelessly and passionately until his last day as Chairman and CEO of MariMed to fulfill our mission of improving people’s lives, much as he did as a philanthropist who cared so deeply about the people and community around him,” said Jon Levine, President of MariMed. “He was my business partner and dear friend, and I look forward to honoring his legacy by achieving our shared vision for the Company. He was one-of-a-kind and will be deeply missed by his family, his wide circle of friends, the cannabis community that he helped build, and the entire MariMed family.”

Mr. Fireman served as CEO of MariMed since 2017 and a member of its Board of Directors since the company’s formation. An early pioneer and visionary in the industry, under his leadership the MariMed team applied for and was awarded legal cannabis licenses in several states across the United States and developed and operated state of the art, regulatory compliant cannabis cultivation, production, and retail facilities.

A practicing attorney for over 30 years, Mr. Fireman’s legal acumen and entrepreneurial experience in diverse industries served were instrumental in navigating MariMed through the complex, highly-regulated, emerging cannabis industry.

Mr. Fireman is survived by his wife and partner for more than 40 years, Ellen Porter Fireman.

"On behalf of the entire MariMed family, we extend our deepest condolences to Ellen and the Fireman and Porter families," said Mr. Levine.

ABOUT MARIMED

MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty’s Eddies, Nature’s Heritage, Bubby’s Baked, K Fusion,

Kalm Fusion, and Vibations: High + Energy. For additional information, visit www.marimedinc.com.

For More Information, Contact:

Investor Relations:

Steve West, Vice President, Investor Relations

Email: ir@marimedinc.com

Phone: (781) 277-0007

Media Contact:

Howard Schacter, Chief Communications Officer

Email: h.schacter@marimedinc.com